American Parkinson Disease Association Welcomes Two Accomplished Leaders to National Board Of Directors
PR Newswire
NEW YORK, June 10, 2025
New Board Members Bring Deep Expertise in Health Equity, Policy, and Nonprofit Leadership to APDA
NEW YORK, June 10, 2025 /PRNewswire-PRWeb/ -- The American Parkinson Disease Association (APDA) is proud to announce the appointment of two distinguished professionals to its National Board of Directors: J. Zoë Beckerman, JD, MPH and Adalynn E. Harris, PhD, MPH, MHA. Both bring deep expertise in health policy, medical research, and community advocacy that will be instrumental in advancing APDA's mission to provide the support, education, research and community that helps everyone impacted by Parkinson's disease live life to the fullest. APDA's National Board is responsible for providing strategic leadership, fiduciary oversight, and governance to ensure APDA fulfills its mission effectively and sustainably.
J. Zoë Beckerman, JD, MPH serves as Vice Chair for Academics and is a Teaching Professor in the Department of Health Policy & Management at the Milken Institute School of Public Health of the George Washington University in Washington DC. A dynamic legal and public policy practitioner, Beckerman has a long track record of strengthening and reforming health and social services systems through research, advocacy, and education. Her areas of expertise include nonprofit governance, Medicaid, corporate compliance, health care access and delivery, and much more. Excited for her new role, Beckerman states, "APDA's work for people with Parkinson's and their families and caregivers is critically important and I look forward to helping guide and support its new additional focus on policy work."
Adalynn E. Harris, PhD, MPH, MHA is the Founder and President of Equity Bridge Consulting, a firm focused on medical affairs consulting for marginalized communities. With more than 25 years of dedication to health equity and community engagement and 15 years of experience in the pharmaceutical industry specializing in oncology and rare diseases, Dr. Harris has been a champion for diversity in clinical trials and public health policy. Her work amplifies the voices of underrepresented communities and facilitates critical collaborations across healthcare sectors. Upon her appointment to the Board, Harris shared, "Joining the Board of Directors of the American Parkinson Disease Association is deeply meaningful to me, both personally and professionally. My mother lived with Parkinson's disease, and I witnessed firsthand the challenges it brings to individuals and their families. I'm honored to help advance APDA's mission - supporting research, providing education and resources, and improving the lives of those impacted by this disease."
Beckerman and Harris will each serve an initial three-year term, with the potential to be re-elected. "We are thrilled to officially welcome Zoë and Adalynn to the APDA Board of Directors," said Leslie A. Chambers, President and CEO of the American Parkinson Disease Association. "Their vast experience in health policy, equity, education, and systems change is a tremendous asset to our organization. They are joining an incredibly passionate and committed Board — some members with connections reaching back to APDA's founding more than 60 years ago. This is an opportune time for their leadership, as we embark on a new three-year strategic plan and confront the evolving challenges facing nonprofit organizations and medical research today."
The addition of Beckerman and Harris reflects APDA's ongoing commitment to leadership, forward-thinking strategy, and innovative approaches to improving the lives of those impacted by Parkinson's disease.
To learn more, visit http://www.apdaparkinson.org, email apda@apdaparkinson.org or call 800-223-2732.
About the American Parkinson Disease Association:
The American Parkinson Disease Association (APDA) is a nationwide grassroots network dedicated to fighting Parkinson's disease (PD) and works tirelessly to help the more than one million people with PD in the United States live life to the fullest in the face of this chronic, neurological disorder. Founded in 1961, APDA has raised and invested more than $313 million to provide outstanding patient services and educational programs, elevate public awareness about the disease, and support research designed to unlock the mysteries of PD and end this disease. To join in the fight against Parkinson's disease and to learn more about the support APDA provides nationally through a network of Chapters and Information & Referral (I&R) Centers, as well as a national Research Program and Centers for Advanced Research, please visit us at http://www.apdaparkinson.org.
Media Contact
Eloise Caggiano, American Parkinson Disease Association, 718-737-8151, ecaggiano@apdaparkinson.org, www.apdaparkinson.org
View original content to download multimedia:https://www.prweb.com/releases/american-parkinson-disease-association-welcomes-two-accomplished-leaders-to-national-board-of-directors-302477487.html
SOURCE American Parkinson Disease Association
